The OTA’s operating result for 2020–21 was a deficit of $0.114 million, compared with the forecast loss of $0.512 million for unfunded depreciation and amortisation expenses. The movements in expenses was largely due to staffing movements and reduced travel costs following travel restrictions during the pandemic. The OTA’s commitment to financial management is reflected in its financial performance and unqualified financial statements.
The OTA received $5.276 million in revenue from Government in 2020–21, compared to $5.308 million in 2019–20. The decrease reflects Government savings measures and efficiencies applied.
The OTA’s expenses for 2020–21 was $5.683 million, largely consistent with expenditure in 2019–20 (2% increase).
The reduction in expenses compared with budget was largely due to unanticipated staff movements during the year and a decrease in travel costs following COVID-19 travel restrictions.
Net asset position
Net assets increased from 2019–20 to 2020–21, primarily driven by a reduction in lease liability on the right-of-use asset and reduction in employee provisions.
Total assets decreased by $0.077 million to $4.656 million (2019–20: $4.733 million), largely due to the depreciation on the right-of-use asset offset by increased cash and appropriation receivable balances at 30 June.
Total liabilities decreased by $0.226 million to $2.299 million (2019–20: $2.525 million). The decrease is due to the reduction in lease liability on the right-of-use asset and reduction in employee provisions as a consequence of staff movements during the year.
In 2020–21, the OTA received a capital budget of $0.262 million. Capital expenditure during the year included enhancements to the Electronic Donor Record, the DonateLife website and purchases of minor computer equipment.
Administered income was received of $1.931 million which largely represented contributions received from the Commonwealth Department of Health towards OrganMatch support.
For 2020–21, the OTA reported supplier expenses of $1.613 million. Supplier expenses primarily related to costs associated with:
+ Electronic Donor Record (EDR) licensing and support
+ increasing community awareness and education through creative material production, public relations and merchandise and delivery of the national Professional Education Package across Australia including delivery of eLearning modules to our health professionals and development of a web-based platform to host professional development sessions for Donation Specialist Donor Coordinators who participate in donor family conversations
+ additional donor family support resources as well as development of a web-based platform to host professional development sessions for Donation Specialist Donor Coordinators who participate in donor family conversations.
Grant expenses were $45.357 million. Funding was provided by the OTA to:
+ state and territory governments for dedicated organ donation specialists in hospitals and donation agencies as well as delivery of professional education public and some private hospitals, contributing to the costs associated with organ donation activity based on actual and intended organ donors
+ deliver the Australian organ matching system – OrganMatch
+ partner with community organisations to promote family discussion, knowledge and registration on the Australian Organ Donor Register.
As at 30 June 2021, the OTA held total assets of $1.098 million which is $0.362 million higher than the previous year, resulting from the recognition of prepaid Electronic Donor Record (EDR) licences.
Total administered liabilities increased by $3.701 million resulting from an increase in grants payable at 30 June.
The OTA received an unqualified audit report from the Australian National Audit Office. The above section should be read in conjunction with the OTA’s 2020–21 audited financial statements, presented in Part 4 – Financial Statements and include the independent auditor’s report and statement by the Accountable Authority and Chief Financial Officer.
Table 5 Organ and Tissue Authority Resource Statement 2020–21
Actual available appropriation for 2020–21
Balance remaining 2020–21
Ordinary annual services1
Total ordinary annual services
Total available annual appropriation and payments
Total resourcing and payments
Total net resourcing and payment for Organ and Tissue Authority
Table 6 Expenses for Outcome 1
Actual expenses 2020–21
Program 1.1: A Nationally Coordinated System for Organ and Tissue Donation for Transplantation
Ordinary annual services (Appropriation Act No. 1)
Expenses not requiring appropriation in the budget year
Total for Program 1.1
Total expenses for Outcome 1
Average staffing level (number)